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Abstract The purpose of this paper is to find out whether
serum oxidizability potential measured before an exercise test
(EXT) correlates with age and ischemic heart disease severity.
Oxidizability potential was determined in 3 age groups, in gr. I
patients<45 years, in gr. II age range ¼ 45 70years, and in
gr. III patients>70 years. Included subjects had chronic
ischemic heart disease (IHD) and underwent a symptom-
limited EXT upon initiation of a cardiac rehabilitation
program. The thermo-chemiluminescence (TCL) assay was
used to assess serum oxidizability potential. This assay is
based on heat-induced oxidation of serum, leading to the
formation of electronically excited species in the form of
unstable carbonyls, which further decompose into stable
carbonyls and light energy (low chemiluminescence). Mea-
sured photons emission is represented by a kinetic curve
which is described by its amplitude and slope (=ratio). We
assessed the correlations of TCL ratio with age, exercise
duration, metabolic equivalents (METS), maximal heart rate
(mHR), maximal systolic BP, >1 mm S-T depression,
diabetes, hypertension, smoking, left ventricular ejection
fraction (LVEF)> or <40%, previous myocardial infarction,
and aorto-coronary bypass surgery. A high TCL ratio (%)
correlated well with METS (r=0.82), mHR (r=0.77) and
with exercise-induced S-T segment shift (r=0.86, p<0.05).
A lower serum oxidizability potential, expressed as a low
TCL ratio, thus suggestive of a previous high oxidative
stress, was found in the two older age groups compared to gr.
I (<45 years), p=0.041, and in particular, in gr. III patients
with low LVEF%. The TCL ratio (%) in gr. III was 188.7±
14.5, 192±17 in gr. II, and 214±13 in gr. I (p<0.05), and
was 166±13.1 in gr. III with LVEF<45% as compared to
271±15.7 in gr. I patients with LVEF>45% (p<0.01). A
trend for lower TCL ratio (%) was found in diabetic,
hypertensive, and post-coronary bypass surgery patients. A
paradoxically low TCL ratio (low oxidizability potential)
was observed in patients without S-T depression compared
to patients with S-T depression (189±22 vs. 201±15, p=
NS), due to the fact these patients had a much lower LVEF%
and a lower exercise capacity. Serum oxidizability potential
is associated with age, EXT parameters, results, and IHD
severity. TCL ratio is an “easy-to-measure marker” that
might be incorporated into risk assessment and prediction in
aged IHD patients.
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Introduction
Oxidative stress reflects a condition in which the balance
between reactive oxygen species (ROS) production and the
subsequent response of the antioxidant defense system is
lost, becoming skewed in favor of free radical expression
[1–3]. Although a multitude of free radicals exists (hydro-
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gen atoms, transition metal ions, carbon-centered radicals,
sulfur-centered radicals, etc.), those derived from oxygen
are referred to as ROS. ROS are highly reactive and very
unstable molecules, which tend to initiate chain reactions
resulting in irreversible chemical changes of lipids and
proteins. These potentially deleterious reactions can result
in profound cellular dysfunction and even cytotoxicity [4].
Aging is an inherently complex process that is man-
ifested within an organism at genetic, molecular, cellular,
organ, and system levels. Although the fundamental
mechanisms are still poorly understood, a growing body
of evidence points toward ROS as one of the primary
determinants of aging. The “oxidative stress theory” holds
that a progressive and irreversible accumulation of oxida-
tive damage caused by ROS impacts on critical aspects of
the aging process and contributes to impaired physiological
function, increased incidence of disease, and a reduction in
life span. While compelling correlative data have been
generated to support the oxidative stress theory, a direct
cause-and-effect relationship between the accumulation of
oxidatively mediated damage and aging has not been
strongly established [5, 6].
Recent data imply that measurement of oxidizability is a
key to kinetic evaluation of oxidative processes of LDL,
blood serum and other body fluids, and can be used for
monitoring the oxidative stress in different diseases and
antioxidant drug therapy [5–9]. The oxidizability of a
biological sample is a measure of its susceptibility to
oxidation. Growing evidence indicates that chronic and
acute overproduction of ROS under pathophysiologic
conditions is important for the development of cardiovas-
cular diseases (CVD). ROS mediate various signaling
pathways that underlie vascular inflammation in atherogen-
esis: from the initiation of fatty streak development through
lesion progression to ultimate plaque rupture. Oxidative
stress is the unifying mechanism for many CVD risk
factors, which additionally supports its central role in CVD
[10].
Evidence for increased oxidative stress has been found
in plasma of patients with ischemic and nonischemic
cardiomyopathy and correlates directly with the severity
and chronicity of symptoms, and inversely with left
ventricular ejection fraction (LVEF) [11, 12].
Free radical injury has also been implicated in the
pathogenesis, evolution, and progression of heart failure
[9, 13–15]. Furthermore, with the evolution of heart failure,
there is a progressive increase in free radical injury and
reduction of antioxidant reserves, which impacts signifi-
cantly on prognosis.
Single bouts of aerobic and anaerobic exercise can
induce an acute state of oxidative stress. This is indicated
by an increased presence of oxidized molecules in a variety
of tissues. Exercise mode, intensity and duration, as well as
the kind of population under study, can impact on the extent
of oxidation [16–22]. Exercise-induced oxidative stress has
been investigated during and after exercise in chronic heart
disease and chronic heart failure patients [13, 23, 24].
Most studies have shown an increased oxidative stress
pre - and post-exercise However, no study has assessed the
relationship between age, pre-exercise oxidizability poten-
tial, exercise test parameters, and EXT results.
Materials and methods
Selection of patients
Fifty-six chronic IHD patients, 13 females and 43 males,
11≤45 years (gr. I), 27 in age range 45–70 years (gr. II),
and 18≥70 years (gr. III). Forty-seven patients (83.9%) had
a previous myocardial infarction, 20 (35.7%) had an aorto-
coronary bypass surgery (CABG), and 35 (62.5%) had a
previous percutaneous intervention (PCI). Eighteen patients
(32.1%) had diabetes mellitus (DM), 34 (60.7%) hyperten-
sion, and 35 (62.5%) dyslipidemia. Thirty-nine patients
(69.6%) were in New York Heart Association (NYHA)
classes II–III, and 17 (30.3%) in class I; patients in NYHA
class IV were not included.
Twenty-nine patients (51.7%) had LVEF<40%, and 27
(48.2%) had an ejection fraction (EF)>40%, including four
patients who had normal EF (≥55%). Patients with an acute
or recent febrile illness, significant liver dysfunction, or
renal failure (serum creatinine≥2.0 mgr%) were excluded
from the study (Table 1).
Subjects regularly using antioxidant supplements (vita-
mins A, C, E, or Co-Enzyme Q-10) or drugs with presumed
antioxidant properties (statins, carvedilol) were required to
stop these medications 7 days prior to the test.
All subjects underwent a symptom-limited EXT upon
initiation of a cardiac rehabilitation program; prior to the
EXT, a 2-mL venous blood sample was drawn for thermo-
chemiluminescence (TCL) assay. Determination of TCL
and oxidizability potential Photons emission during heating
was measured by TCL analyzer (manufactured by Lumitest
Ltd., Caesarea, Israel) using a photomultiplier model
R265P (Hamamatsu Photonics Co. Ltd. Ichino-cho,
Higashi-ku, Hamamatsu City, Japan) with a spectral
response range of 280–650 nm. The computer program of
the device has two main functions: (1) analysis of the
sample preparation (0.05 mL of serum required for the test),
(2) data processing, display, and storage. The serum under
exam was spread over the surface of aluminum tray (a kind
of miniature Petri dish) inside the sample preparation block
and then was vacuum-dried. Then, the dish was mounted
on a constant heater with heating temperature 80±0.5 s.d.
the analysis block and the photons emission was measured
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each second for 300 s. The obtained TCL curve was
described mathematically as the amplitude of the kinetic
curve of the photons emission and slope of the curve. The
obtained curve is described mathematically as the ampli-
tude of the kinetic curve and its slope (=ratio), which
reflects the heat-induced susceptibility to oxidative modifi-
cation of the tested sample, i.e., the residual oxidative
capacity due to prior in vivo molecular oxidation. Thus, a
lower curve slope suggests a lower oxidative potential,
indicating higher oxidative activity before test.
Statistical analysis
Statistical analysis was performed using SPSS v15.0
(Chicago, IL, USA) and data were presented as means±
SD. Student's t test was used, due to the normal distribution
of results, and correlations were determined by Pearson's
coefficient. Associations were considered statistically sig-
nificant when the P value was <0.05. Regression analysis
was performed in order to find out the independent
variables with the most evident impact on TCL ratio.
Results
A lower serum oxidizability potential, expressed as a low
TCL ratio, suggestive of a previous, high oxidative stress,
was found in the older age groups (II and III) compared to
the younger age group (I), p<0.05 and p<0.01.
The lowest values of TCL were found among gr. III
patients with low LVEF% (Fig. 1).
TCL ratio (%) was 229±15 in gr. I, 193±21 in gr. II, and
188±14.7 in gr. III, (p<0.05 and p<0.01).
Gr. III patients with low LVEF (<40%) had a TCL ratio
of 177±12.1 compared to 200±11.9 in patients in the same
group with a better LVEF (> 40%), p<0.01.
The TCL ratio correlated well with exercise tolerance
expressed in metabolic equivalents as well with exercise
duration (r=0.88 and 0.91, p<0.01, respectively). Simi-
larly, TCL ratio correlated with exercise maximal heart
rate (r=0.79) and with exercise-induced ≥1 mm ST segment
shift (r=0.77). A trend for lower TCL ratio (%) was found in
diabetic, hypertensive, and post-CABG patients (193±14,
194±17, and 196±13, respectively, p=ns).
A paradoxically low TCL ratio (low oxidizability
potential) was observed in patients without S-T depression














Fig. 1 TCL ratio in older patients with LVEF≤ or ≥40%
Gr. I Gr. II Gr. III
Patients No. 11 27 18
S-T depression > 1 mm ↓ 2 (18.2%) 19 (70.4%) 12 (66.7%)
METS 10.9±0.6 7.4±0.5 5.5±0.6
Exercise Duration (min) 11.2±1.1 7.5±0.8 6.2±0.5
Max Systolic BP (mmHg) 178±10 147±11 152±12
Max HR (bpm) 159±11 141±9 127±6
F.C. I 11 (100%) 3 (15.8%) 3 (25%)
F.C. II–III 0 16 (84.2%) 9 (75%)
EF%<40 0 17 (62.9%) 12 (66.7%)
EF%>40 11 (100%) 10 (37.15) 6 (33.3%)
Previous M.I. 4 (36.4%) 27 (100%) 16 (88.9%)
Previous ACBG 1 (9.1%) 15 (55.6%) 3 (16.7%)
Previous PCI 6 (54.5%) 24 (88.9%) 5 (27.8%)
Dyslipidemia 7 (63.6%) 17 (62.9%) 11 (61.1%)
Current Smokers 3 (27.3%) 9 (33.3%) 2 (11.1%)
Diabetes 0 9 (33.3%) 6 (33.3%)
Table 1 Demographic and
clinical data
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15, p=ns), due to the fact that these patients had a much
lower LVEF% and a lower exercise capacity.
Regression analysis showed that older age≥70, and left
ventricular EF% were the best independent predictor of the
TCL ratio (R2=0.87208, R=0.9338, St Err=17.76, Adj F=
0.87118, n=144, p<0.001).
Discussion
Reactive oxygen species and other oxidants are implicated
in the mechanisms of biological aging and exercise-induced
tissue damage.
The TCL assay used in our study is one among the
accepted, validated, and reproducible methods [9–11] for
measurement of oxidative stress and serum oxidizability
potential. This assay is based on the heat-induced oxidation
of a sample leading to the formation of electronically
excited species (in particular of triplet excited carbonyls)
and of light energy, low-level chemiluminescence.
Aging is associated with increased free radical genera-
tion in the skeletal muscle that can cause oxidative
modification of protein, lipid, and DNA [5, 6, 25, 26].
Physical activity has many well-established health benefits,
but strenuous exercise increases muscle oxygen flux and
elicits intracellular events that can lead to increased
oxidative injury. The paradox arises as to whether exercise
would be advisable to aged population. Research evidence
indicates that senescent organisms are more susceptible to
oxidative stress during exercise because of the age-related
ultrastructural and biochemical changes that facilitate
formation of ROS.
Increased ROS production has been shown to impair
endothelium-dependent vasorelaxation, to cause myocyte
apoptosis, to increase monocyte adhesion, and inflammato-
ry gene expression, thus contributing to myocardial and
skeletal muscle contractile dysfunction and deterioration in
congestive heart failure (CHF) patients [15].
Only a few studies have addressed the issue of oxidative
stress in relation to age and exercise, and most of them
were conducted on animals [27, 28].
In studies involving chronic IHD and CHF patients, a
significant increase in exercise-induced plasma oxidative
stress was found. Exercise mode, intensity, and duration, as
well as the subject population tested, all can certainly
impact the extent of oxidation [18–23, 29–31]. However,
these studies disagree when pre-exercise oxidative status is
examined. Sayar et al. [15] failed to find a significant
difference in resting plasma oxidative stress in CHF
patients as compared with controls, the likely reason for
these unexpected findings being that the control group
contained patients with many cardiovascular risk factors
rather than healthy controls. Thus, it was suggested that the
underlying risk factors may be associated with an increase
in resting pre-exercise plasma malondialdehyde levels.
Díaz-Vélez et al. [32] have reported similar findings
concerning the resting plasma oxidative stress in symptom-
atic CHF patients (LVEF<40%), and in asymptomatic
patients with LVEF>40% without clinical evidence of
CHF but with hypertension, DM or a history of myocardial
infarction. On the other hand, in the study of Belch et al.
[33], there was a significant, negative correlation between
LVEF and oxidative stress.
No study so far has addressed the question whether the
pre-exercise oxidative status is related to the age of the
tested patients, and whether it may have an impact on EXT
results, thus contributing to the risk assessment of these
patients.
Our findings suggest that previous, chronic, or recurrent
oxidative stress in older IHD patients practically reduces
and depletes residual oxidative capacity. In other words,
residual oxidative capacity is decreased due to prior
recurrent in vivo molecular oxidation in these patients.
The study proves that the older the patient is, the sicker
he is, with lower EF%, and lower exercise capacity, then,
the lowest serum oxidizability potential, reflected by the
lowest TCL ratio, is expected. Thus, assessment of TCL
ratio at resting conditions may predict EXT results and,
therefore, support risk assessment in chronic IHD patients
according to their age group. Oxidizability potential assess-
ment may have clinical applications in the routine follow-up
of the atherosclerotic disease in elderly obese, diabetic, and
hypertensive patients, as well as in elderly treated with drugs,
vitamins, and food supplements with alleged or proved anti-
atherogenic or pro-atherogenic properties.
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